鹏华上证科创板生物医药ETF
(588250)公募股票型指数型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-03-31 | 2.61 | 2.60 | 2.59 | 99.30% | 99.29% | 0.00 | 0.00% | 0.00% | 0.02 | 0.67% | 0.67% | 0.00 | 0.03% | 0.04% |
| 2025-12-31 | 2.10 | 2.10 | 2.07 | 98.59% | 98.60% | 0.00 | 0.00% | 0.00% | 0.03 | 1.41% | 1.40% | 0.00 | 0.00% | 0.00% |
| 2025-09-30 | 2.09 | 2.08 | 2.05 | 98.39% | 98.39% | 0.00 | 0.00% | 0.00% | 0.03 | 1.59% | 1.59% | 0.00 | 0.02% | 0.02% |
| 2025-06-30 | 1.01 | 1.01 | 0.99 | 98.26% | 98.26% | 0.00 | 0.00% | 0.00% | 0.02 | 1.65% | 1.65% | 0.00 | 0.09% | 0.09% |